NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 56,400 shares, a decrease of 39.1% from the October 31st total of 92,600 shares. Based on an average daily volume of 1,100,000 shares, […]
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report)’s share price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.78 and traded as low as $0.43. NovaBay Pharmaceuticals shares last traded at $0.46, with a volume of 50,433 shares changing hands. Analyst Ratings Changes Separately, […]
Should You Buy or Sell NovaBay Pharmaceuticals Stock? Get The Latest NBY Stock Forecast, Price Target, Earnings Estimates, and Headlines at MarketBeat.
StockNews.com began coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Free Report) in a research note published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Trading Up 2.7 % Shares of NYSEAMERICAN NBY opened at $0.77 on Tuesday. The firm has a market capitalization of $1.44 million, […]
StockNews.com assumed coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research report sent to investors on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Trading Up 9.5 % Shares of NYSEAMERICAN NBY opened at $0.88 on Friday. NovaBay Pharmaceuticals has a 12 month low of […]